RGEN

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Repligen (RGEN) Earnings Date & Reports

Industry: @Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

RGEN is expected to report earnings to fall 4.33% to 41 cents per share on February 19

Q4'24

Est.

$0.41

Q3'24

Beat

by $0.10

Q2'24

Est.

$0.33

Q1'24

Missed

by $0.02

Q4'23

Est.

$0.33

The last earnings report on November 12 showed earnings per share of 43 cents, beating the estimate of 33 cents. With 104.64K shares outstanding, the current market capitalization sits at 10.26B.

View a ticker or compare two or three

Compare

RGEN

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For RGEN
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for RGEN (Try 14 days for Free)

A.I. Advisor

published General Information

General Information

a developer of biologic drugs

Industry MedicalSpecialties

Profile

Fundamentals

Details

Industry

Biotechnology

Address

41 Seyon Street

Phone

+1 781 250-0111

Employees

1783

Web

https://www.repligen.com